Retatrutide is an investigational injectable medication currently under clinical development for the treatment of obesity and overweight
If you experience any of the following, remain at your current dose for an additional 2 to 4 weeks before escalating: Nausea lasting more than 3 days after injection Vomiting more than once per week Inability to maintain adequate caloric intake (under 1,000 calories daily) Signs of dehydration despite increased fluid intake New onset of significant fatigue that interferes with daily function Slowing escalation is not failure
Our providers bring extensive experience in medical weight loss, honest assessment of candidacy and expectations, ongoing monitoring and dosing adjustments, and immediate support if concerns arise
18 Despite being a conditionally essential nutrient, carnitine is a topic of uncertainty, even controversy, because its like a coin with two sides, and those sides can appear to be in direct conflict with each other
First, it prevents the growth of bacteria in the solution once the vial has been opened and the peptide has been mixed
The volume you add determines the concentration of your reconstituted solution